Recent Quotes (30 days)

You have no recent quotes
chg | %

Clinigen Group PLC  

(Public, LON:CLIN)   Watch this stock  
719.33
+5.83 (0.82%)
Dec 9 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 700.00 - 730.50
52 week 492.75 - 793.50
Open 700.00
Vol / Avg. 577,635.00/377,823.00
Mkt cap 827.90M*
P/E 61.16
Div/yield 2.70*
EPS 0.12*
Shares 115.09M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 6.47% 3.97%
Operating margin 8.91% 5.94%
EBITD margin - 19.36%
Return on average assets 5.19% 3.07%
Return on average equity 10.31% 6.12%
Employees 86 -
CDP Score - -

Address

Pitcairn House Crown Square, First Avenue
BURTON UPON TRENT, DE14 2WW
United Kingdom - Map
+44-1283-495010 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Officers and directors

Peter Lutz George Non-Executive Director
Martin James Abell Chief Financial Officer - Elect, Director
Age: 41
Shaun Edward Chilton Chief Executive Officer, Director
Age: 46
Peter Vance Allen Independent Non-Executive Chairman of the Board
Age: 58
John Bacon Non-Executive Director
John Hartup Independent Non-Executive Director
Ian J. Nicholson Independent Non-Executive Director
Age: 54